Hillman Capital Management, Inc.: CVS HEALTH CORP (CVS): Quarterly 13F Position History
As of Q1 2026, Hillman Capital Management, Inc. reported 67,462 shares of CVS HEALTH CORP (CVS), worth $4.8M and representing 3.4% of its 13F equity book. Quarter-over-quarter share count change: 4,223 (-5.9%) . The position first appeared in Q4 2019 and has been disclosed across 26 13F-HR filings in Pactolio's tracked window.
- 67,462Shares Held (Latest Filing)
- $4.8MReported Market Value (Latest Filing)
- 3.4%Portfolio Weight (% of 13F Equity Book)
- 4,223Quarter-over-Quarter Share Change
- -$843.8KQuarter-over-Quarter Value Change
- 124,329Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 26 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 67,462 | 4,223 | -5.9% | $4.8M | 3.4% | $71.8 |
| Q4 2025 | 71,685 | 10,674 | -13.0% | $5.7M | 3.6% | $79.4 |
| Q3 2025 | 82,359 | 10,638 | -11.4% | $6.2M | 3.6% | $75.4 |
| Q2 2025 | 92,997 | 7,453 | -7.4% | $6.4M | 3.5% | $69.0 |
| Q1 2025 | 100,450 | 19,186 | -16.0% | $6.8M | 3.3% | $67.8 |
| Q4 2024 | 119,636 | 1,891 | -1.6% | $5.4M | 2.0% | $44.9 |
| Q3 2024 | 121,527 | 2,802 | -2.3% | $7.6M | 2.6% | $62.9 |
| Q2 2024 | 124,329 | +10,291 | +9.0% | $7.3M | 2.6% | $59.1 |
| Q1 2024 | 114,038 | +376 | +0.3% | $9.1M | 2.9% | $79.8 |
| Q4 2023 | 113,662 | +1,354 | +1.2% | $9.0M | 3.1% | $79.0 |
| Q3 2023 | 112,308 | +16,613 | +17.4% | $7.8M | 3.0% | $69.8 |
| Q2 2023 | 95,695 | 652 | -0.7% | $6.6M | 2.3% | $69.1 |
| Q1 2023 | 96,347 | +712 | +0.7% | $7.2M | 2.7% | $74.3 |
| Q4 2022 | 95,635 | 707 | -0.7% | $8.9M | 3.5% | $93.2 |
| Q3 2022 | 96,342 | 968 | -1.0% | $9.2M | 3.8% | $95.4 |
| Q2 2022 | 97,310 | 173 | -0.2% | $9.0M | 3.3% | $92.7 |
| Q1 2022 | 97,483 | 11,615 | -10.6% | $9.9M | 3.1% | $101.2 |
| Q4 2021 | 109,098 | 3,743 | -3.3% | $11.3M | 3.9% | $103.2 |
| Q3 2021 | 112,841 | +3,912 | +3.6% | $9.6M | 3.4% | $84.9 |
| Q2 2021 | 108,929 | +710 | +0.7% | $9.1M | 3.5% | $83.4 |
| Q1 2021 | 108,219 | +13,954 | +14.8% | $8.1M | 3.6% | $75.2 |
| Q4 2020 | 94,265 | +13,169 | +16.2% | $6.4M | 3.5% | $68.3 |
| Q3 2020 | 81,096 | +10,158 | +14.3% | $4.7M | 3.3% | $58.4 |
| Q2 2020 | 70,938 | +18 | +0.0% | $4.6M | 3.4% | $65.0 |
| Q1 2020 | 70,920 | 286 | -0.4% | $4.2M | 4.0% | $59.3 |
| Q4 2019 | 71,206 | — | — | $5.3M | 3.7% | $74.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Hillman Capital Management, Inc. first disclose a CVS position in 13F-HR filings?
Hillman Capital Management, Inc. first reported CVS HEALTH CORP (CVS) on its 13F-HR filing for the period ending 2019-12-31 (Q4 2019). The position has appeared on 26 reported quarters within Pactolio's tracked window.
What was Hillman Capital Management, Inc.'s most recent quarter-over-quarter share-count change in CVS?
Between Q4 2025 and Q1 2026, Hillman Capital Management, Inc. reduced its CVS position by 4,223 shares (-5.9%), leaving 67,462 shares at a market value of $4.8M.
Does the implied price-per-share represent Hillman Capital Management, Inc.'s cost basis in CVS?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.